Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

FromThe Credit Edge by Bloomberg Intelligence


Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

FromThe Credit Edge by Bloomberg Intelligence

ratings:
Length:
34 minutes
Released:
Jan 11, 2024
Format:
Podcast episode

Description

Private-debt firms are set to consolidate as larger companies dominate deal flow, according to Marc Chowrimootoo, portfolio manager at Hayfin Capital Management. “We’re seeing a concentration within fewer hands,” Chowrimootoo tells Bloomberg News’ Lisa Lee and James Crombie and Bloomberg Intelligence’s Julie Hung in the latest Credit Edge podcast. “That trend is going to continue.” He identifies debt refinancing as the big opportunity for private lenders in 2024. Hayfin likes the health-care and software sectors, while avoiding smaller borrowers that are struggling with higher rates. In addition, BI’s Hung weighs the impact on food and drink companies of weight-loss drugs like Ozempic.See omnystudio.com/listener for privacy information.
Released:
Jan 11, 2024
Format:
Podcast episode

Titles in the series (67)

The Credit Edge reviews the top credit news of the week and looks at the week ahead, with in-depth research of the most important corporate sectors, trends and themes. Analysis of specific corporate bonds and credit default swaps is backed by Bloomberg Intelligence's robust data sets and indexes.